Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.
Gomez-Gaitan EA, Garcia-Ortega YE, Saldaña-Cruz AM, Contreras-Haro B, Gamez-Nava JI, Perez-Guerrero EE, Nava-Valdivia CA, Gallardo-Moya S, Martinez-Hernandez A, Gonzalez Lopez L, Rios-Gonzalez BE, Marquez-Pedroza J, Mendez-Del Villar M, Esparza-Guerrero Y, Villagomez-Vega A, Macias Islas MA.
Gomez-Gaitan EA, et al. Among authors: rios gonzalez be.
Int J Mol Sci. 2023 Sep 27;24(19):14594. doi: 10.3390/ijms241914594.
Int J Mol Sci. 2023.
PMID: 37834042
Free PMC article.